Eligard Kit is owned by Tolmar Therap.
Eligard Kit contains Leuprolide Acetate.
Eligard Kit has a total of 1 drug patent out of which 0 drug patents have expired.
Eligard Kit was authorised for market use on 24 July, 2002.
Eligard Kit is available in powder;subcutaneous dosage forms.
Eligard Kit can be used as method of treating cancer.
The generics of Eligard Kit are possible to be released after 15 October, 2023.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US8470359||TOLMAR THERAP||Sustained release polymer|| |
(4 months from now)
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Market Authorisation Date: 24 July, 2002
Treatment: Method of treating cancer
Korea, Republic of
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic